Leritrelvir Tablets.

Effects and efficacy:
For the treatment of adult patients with mild to moderate novel coronavirus infection (COVID-19).
Usage and dosage:
Oral, with meals. It should be used as soon as possible within 2 days of the first onset of symptoms. The recommended dose of this product is 0.4g (2 tablets) each time, three times a day, for 5 consecutive days.
Adverse reactions:
Possible adverse reactions of Leretevir tablets: Metabolic and nutritional diseases: hypertriglyceridemia, hyperlipidemia, hyperuricemia, hypercholesterolemia, most of which are grade 1 (mild) or grade 2 (moderate), and most of them can recover on their own. Various examinations: Decreased neutrophil count (1.5%), increased alanine aminotransferase (1.6%). Hepatobiliary system diseases: Abnormal liver function (1.6%)
Drug contraindications:
Allergic to this product is prohibited
Pharmaceutical company information: